The profitability of IMMUNITYBIO, INC. over the past 10 years
Chart IMMUNITYBIO, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →IMMUNITYBIO, INC. reported a net loss of $351.4M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $112.53M and an operating loss of $256.03M. It reported a loss in all 10 years shown.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $112.53M* | -$256.03M | -$351.4M |
| 2024ended Dec 31, 2024 | $14.74M* | -$344.18M | -$413.56M |
| 2023ended Dec 31, 2023 | $622K* | -$362.25M | -$583.2M |
| 2022ended Dec 31, 2022 | $240K* | -$351.3M | -$416.57M |
| 2021ended Dec 31, 2021 | — | -$330.28M | -$346.79M |
| 2020ended Dec 31, 2020 | — | -$220.88M | -$221.85M |
| 2019ended Dec 31, 2019 | — | -$156.25M | -$157.78M |
| 2018ended Dec 31, 2018 | — | -$98.39M | -$96.23M |
| 2017ended Dec 31, 2017 | — | -$99.12M | -$96.42M |
| 2016ended Dec 31, 2016 | — | -$124.5M | -$120.81M |
Fiscal years as IMMUNITYBIO, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on IMMUNITYBIO, INC.
- The revenue of IMMUNITYBIO, INC.
- The cash flow of IMMUNITYBIO, INC.
- The debt of IMMUNITYBIO, INC.
- All of IMMUNITYBIO, INC.'s financials, charted
Companies of a similar size
- BRXBrixmor Property Group Inc.
- TTMITTM TECHNOLOGIES, INC.
- REXRRexford Industrial Realty, Inc.
- DBXDropbox, Inc.
- ZETAZeta Global Holdings Corp.
Not investment advice. This page shows what IMMUNITYBIO, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.